Registro:

Referencias:

• Acosta, E.G., Piccini, L.E., Talarico, L.B., Castilla, V., Damonte, E.B., Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells (2014) Virus Res, 184, pp. 39-43
• Alen, M.M.F., Dallmeier, K., Balzarini, J., Neyts, J., Schols, D., Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection (2012) Antiviral Res, 96, pp. 280-287
• Añez, G., Men, R., Eckels, K.H., Lai, C.-J., Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques (2009) J Virol, 83, pp. 10384-10394
• Avirutnan, P., Zhang, L., Punyadee, N., Manuyakom, A., Puttikhunt, C., Kasinrerk, W., Malasit, P., Diamond, M.S., Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E (2007) PLoS Pathogens, 3, p. e183
• Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., Drake, J.M., Hay, S.I., The global distribution and burden of dengue (2013) Nature, 496, pp. 504-507
• Castilla, V., Piccini, L.E., Damonte, E.B., Dengue virus entry and trafficking: Perspectives as antiviral target for prevention and therapy (2015) Future Virol, 10, pp. 625-645
• Chen, Y., Maguire, T., Hileman, R.E., Fromm, J.R., Esko, J.D., Linhardt, R.J., Marks, R.M., Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate (1997) Nat Med, 3, pp. 866-871
• Crill, W.D., Roehrig, J.T., Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells (2001) J Virol, 75, pp. 7769-7773
• Dalrymple, N., Mackow, E.R., Productive dengue virus infection of human endothelial cells is directed by heparin sulfate-containing proteoglycan receptors (2011) J Virol, 85, pp. 9478-9485
• Flipse, J., Wilschut, J., Smit, J.M., Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans (2013) Traffic, 14, pp. 25-35
• Germi, R., Crance, J.M., Garin, D., Guimet, J., Lortat-Jacob, H., Ruigrok, R.W., Zarski, J.P., Drouet, E., Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus (2002) Virology, 292, pp. 162-168
• Guzmán, M.G., Halstead, S.B., Artsob, H., Buchy, P., Farrar, J., Gubler, D.J., Hunsperger, E., Peeling, R.W., Dengue: A continuing global threat (2010) Nat Rev Microbiol, 8, pp. S7-16
• Halstead, S.B., Dengue (2007) Lancet, 370, pp. 1644-1652
• Hilgard, P., Stockert, R., Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes (2000) Hepatology, 32, pp. 1069-1077
• Hung, J.J., Hsieh, M.T., Young, M.J., Kao, C.L., King, C.C., Chang, W., An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells (2004) J Virol, 78, pp. 378-388
• Hung, S.L., Lee, P.L., Chen, H.W., Chen, L.K., Kao, C.L., King, C.C., Analysis of the steps involved in Dengue virus entry into host cells (1999) Virology, 257, pp. 156-167
• Ichiyama, K., Gopala Reddy, S.B., Zhang, L.F., Chin, W.X., Muschin, T., Heinig, L., Suzuki, Y., Yamamoto, N., Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: A possible candidate for clinical application (2013) PLoS Negl Trop Dis, 7, p. e2188
• Kuhn, R.J., Zhang, W., Rossmann, M.G., Pletnev, S.V., Corver, J., Lenches, E., Jones, C.T., Strauss, E.G., Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion (2002) Cell, 108, pp. 717-725
• Lee, E., Wright, P.J., Davidson, A., Lobigs, M., Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination (2006) J Gen Virol, 87, pp. 2791-2801
• Martinez-Barragan, J.J., del Angel, R.M., Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection (2001) J Virol, 75, pp. 7818-7827
• Modis, Y., Ogata, S., Clements, D., Harrison, S.C., A ligand-binding pocket in the dengue virus envelope glycoprotein (2003) Proc Natl Acad Sci USA, 100, pp. 6986-6991
• Modis, Y., Ogata, S., Clements, D., Harrison, S.C., Structure of the dengue virus envelope protein after membrane fusion (2004) Nature, 427, pp. 313-319
• Modis, Y., Ogata, S., Clements, D., Harrison, S.C., Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein (2005) J Virol, 79, pp. 1223-1231
• Nicholas, K.B., Nicholas, H.B., Jr., Deerfield, D.W., II, Genedoc: A tool for editing and annotating multiple sequence alignments (1997) EMB NEW NEWS, 4, p. 14
• Ohkuma, S., Poole, B., Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents (1978) Proc Natl Acad Sci USA, 75, pp. 3327-3331
• Prestwood, T.R., Prigozhin, D.M., Sharar, K.L., Zellweger, R.M., Shresta, S., A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads (2008) J Virol, 82, pp. 8411-8421
• Pujol, C.A., Ray, S., Ray, B., Damonte, E.B., Antiviral activity against dengue virus of diverse classes of algalsulfated polysaccharides (2012) Int J Biol Macromol, 51, pp. 412-416
• Roehrig, J.T., Butrapet, S., Liss, N.M., Bennett, S.L., Luy, B.E., Childers, T., Boroughs, K.L., Huang, C.Y., Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion (2013) Virology, 441, pp. 114-125
• Smit, J.M., Moesker, B., Rodenhuis-Zybert, I., Wilschut, J., Flavivirus cell entry and membrane fusion (2011) Viruses, 3, pp. 160-171
• Stiasny, K., Heinz, F.X., Flavivirus membrane fusion (2006) J Gen Virol, 87, pp. 2755-2766
• Talarico, L.B., Damonte, E.B., Interference in dengue virus adsorption and uncoating by carrageenans (2007) Virology, 363, pp. 473-485
• Talarico, L.B., Noseda, M.D., Ducatti, D.R.B., Duarte, M.E.R., Damonte, E.B., Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan (2011) J Gen Virol, 92, pp. 1332-1342
• Talarico, L.B., Pujol, C.A., Zibetti, R.G., Faria, P.C., Noseda, M.D., Duarte, M.E., Damonte, E.B., The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell (2005) Antiviral Res, 66, pp. 103-110
• Tatusova, T.A., Madden, T.L., BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences (1999) FEMS Microbiol Lett, 174, pp. 247-250
• Thaisomboonsuk, B.K., Clayson, E.T., Pantuwatana, S., Vaughn, D.W., Endy, T.P., Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells (2005) Am J Trop Med Hyg, 72, pp. 375-383
• Vervaeke, P., Alen, M., Noppen, S., Schols, D., Oreste, P., Liekens, S., Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain II (2013) PLoS ONE, 8, p. e74035
• Watterson, D., Kobe, B., Young, P.R., Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding (2012) J Gen Virol, 93, pp. 72-82

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------